新型血管闭合装置在神经介入诊疗中的安全性和有效性评价

目的:评价封闭股动脉穿刺点的新型血管闭合装置Star-Close在神经介入使用中的安全性和有效性。方法:观察神经介入治疗结束后,采用Star-Close装置封闭股动脉穿刺点的304例患者344处穿刺点。部分患者接受同侧腹股沟2次以上穿刺埋鞘并缝合。结果:穿刺部位术后使用Star-Close装置344处,封闭成功328处(95.3%),重大并发症1例,轻微并发症和重大并发症发生率分别为4.4%和0.3%。在同一侧腹股沟重复穿刺并接受再次封闭40例患者成功率92.5%,并发症率7.5%。结论:对于初次和再次穿刺股动脉进行神经介入诊疗的患者,Star-Close均为一种快速和安全有效的血管闭合装置。

The Safety and Efficacy of Deployment about Star-Close Vascular Closure Device in NeuroInterventional Radiology Treatment

Objective:Obtaining safe and effective closure of the femoral access site following neurointerventional treatments can sometimes be challenging,especially in patients on anticoagulation or anti-platelet therapy.The purpose of this study was to evaluate the safety and efficacy of a percutaneous closure device that employs a nitinol clip-mediated closure strategy following neurointerventional treatments.Methods:A retrospective review of 304 patients who underwent neurointerventional procedures was performed.The safety and efficacy of the Star-Close device in patients undergoing first and reaccess punctures were evaluated.Femoral complications were classified as self-limited hematoma,hematoma requiring transfusion,pseudoaneurysm,infection,and other/major(vascular complication).Results:Of 344 sites in which starClose device was used,328 sites were reported to be sucessful(95.3%).Minor and major complications occurred in 4.4% and 0.3% of the patients,respectively.There was one major vascular complication.Repeated use was performed in 40 patients with 92.5% of success and a 7.5% minor complication rate.Conclusion:The Star-Close device achieves rapid and safe femoral arterial closure in patients,both for primary and secondary closure.